Breast Cancer Drug Perjeta Increases Survival in Patients

September 30, 2014 12:14 PM

15 0

Patients who suffer from breast cancer received satisfactory advantages in extending lives because of drug Perjeta.

According to a report from The New York Times, patients who have used the breast cancer drug Perjeta survived close to 16 months longer than those who did not. The drug increased the lives of people with an aggressive kind of metastatic breast cancer.

Read more

To category page